Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Rizzari

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
The Lancet. Oncology|July 28, 2022
The impact of the EU General Data Protection Regulation on childhood cancer research in EuropeGilles Vassal, Deyan Lazarov, Carmelo Rizzari, et al.
Pediatric Blood & Cancer|August 1, 2013
Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapyMartina Chiu, Renata Franchi-Gazzola, Ovidio Bussolati, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2019
Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literatureFabiola Dell'Acqua, Francesco Saettini, Ilaria Castelli, et al.
Health Science Reports|January 8, 2024
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UKStefan Bielack, Christopher P Fox, Khê Hoang-Xuan, et al.
American Journal of Medical Genetics. Part A|November 22, 2016
Acute myeloid leukemia in Baraitser-Winter cerebrofrontofacial syndromePaola Cianci, Grazia Fazio, Sara Casagranda, et al.
European Journal of Clinical Pharmacology|June 15, 2013
Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancerAntonio Ruggiero, Silvia Triarico, Giovanna Trombatore, et al.
Haematologica|September 13, 2003
T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective studyPaola Giordano, Nicola Santoro, Giovanni Carlo Del Vecchio, et al.
Pediatric Blood & Cancer|June 9, 2021
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?Luke Maese, Carmelo Rizzari, Russell Coleman, et al.
American Journal of Medical Genetics. Part A|April 25, 2013
A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1Paola Cianci, Valentina Tono, Alessandra Sala, et al.
Current Research in Translational Medicine|November 21, 2025
Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injuryNicolò Peccatori, Gianluigi Ardissino, Simone Cesaro, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|July 28, 2022
The impact of the EU General Data Protection Regulation on childhood cancer research in EuropeGilles Vassal, Deyan Lazarov, Carmelo Rizzari, et al.
Pediatric Blood & Cancer|August 1, 2013
Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapyMartina Chiu, Renata Franchi-Gazzola, Ovidio Bussolati, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2019
Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literatureFabiola Dell'Acqua, Francesco Saettini, Ilaria Castelli, et al.
Health Science Reports|January 8, 2024
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UKStefan Bielack, Christopher P Fox, Khê Hoang-Xuan, et al.
American Journal of Medical Genetics. Part A|November 22, 2016
Acute myeloid leukemia in Baraitser-Winter cerebrofrontofacial syndromePaola Cianci, Grazia Fazio, Sara Casagranda, et al.
European Journal of Clinical Pharmacology|June 15, 2013
Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancerAntonio Ruggiero, Silvia Triarico, Giovanna Trombatore, et al.
Haematologica|September 13, 2003
T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective studyPaola Giordano, Nicola Santoro, Giovanni Carlo Del Vecchio, et al.
Pediatric Blood & Cancer|June 9, 2021
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?Luke Maese, Carmelo Rizzari, Russell Coleman, et al.
American Journal of Medical Genetics. Part A|April 25, 2013
A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1Paola Cianci, Valentina Tono, Alessandra Sala, et al.
Current Research in Translational Medicine|November 21, 2025
Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injuryNicolò Peccatori, Gianluigi Ardissino, Simone Cesaro, et al.
Pageof 15